Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuhan Chung

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Acta Diabetologica|May 2, 2012
Insulin resistance is associated with elevated serum pigment epithelium-derived factor (PEDF) levels in morbidly obese patientsArijeet K Gattu, Andreas L Birkenfeld, Francois Jornayvaz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2022
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/FirsocostatEric J Lawitz, Bal Raj Bhandari, Peter J Ruane, et al.
Pediatric Research|July 22, 2006
Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft modelMarybeth Browne, Veronica Stellmach, Mona Cornwell, et al.
The American Journal of Pathology|October 4, 2011
Pigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1John C Schmitz, Petr Protiva, Arijeet K Gattu, et al.
Journal of Lipid Research|February 3, 2023
Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrateMohamad Dandan, Julia Han, Sabrina Mann, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosisDahai Zhang, Teruo Utsumi, Hui-Chun Huang, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitisMichael Trauner, Yevgeniy Gindin, Zhaoshi Jiang, et al.
JCI Insight|January 26, 2018
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitisRohit Loomba, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Journal of Lipid Research|July 14, 2022
Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patientsEric J Lawitz, Kelvin W Li, Edna Nyangau, et al.
BMC Gastroenterology|March 16, 2023
PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitisMichael Trauner, Chuhan Chung, Kate Sterling, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Acta Diabetologica|May 2, 2012
Insulin resistance is associated with elevated serum pigment epithelium-derived factor (PEDF) levels in morbidly obese patientsArijeet K Gattu, Andreas L Birkenfeld, Francois Jornayvaz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2022
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/FirsocostatEric J Lawitz, Bal Raj Bhandari, Peter J Ruane, et al.
Pediatric Research|July 22, 2006
Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft modelMarybeth Browne, Veronica Stellmach, Mona Cornwell, et al.
The American Journal of Pathology|October 4, 2011
Pigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1John C Schmitz, Petr Protiva, Arijeet K Gattu, et al.
Journal of Lipid Research|February 3, 2023
Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrateMohamad Dandan, Julia Han, Sabrina Mann, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosisDahai Zhang, Teruo Utsumi, Hui-Chun Huang, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitisMichael Trauner, Yevgeniy Gindin, Zhaoshi Jiang, et al.
JCI Insight|January 26, 2018
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitisRohit Loomba, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Journal of Lipid Research|July 14, 2022
Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patientsEric J Lawitz, Kelvin W Li, Edna Nyangau, et al.
BMC Gastroenterology|March 16, 2023
PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitisMichael Trauner, Chuhan Chung, Kate Sterling, et al.
Pageof 7